Anavex Life Sciences Reports Fiscal 2016 Financial Results

Anavex Life Sciences Reports Fiscal 2016 Financial Results

Conference Call and Webcast Today at 4:30 p.m. ET to Discuss Financial Results and Clinical Progress NEW YORK – December 12, 2016 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company...

Anavex to Participate in Mizuho Therapeutics Conference

Conference to Feature Companies with Focus on Alzheimer’s, Parkinson’s and other Neurological Diseases NEW YORK, NY – September 14, 2016 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical...

Anavex Reports Fiscal Third Quarter 2016 Financial Results

New York, NY – August 11, 2016 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and...